These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 476825)

  • 61. Morphological criteria for the in vitro differentiation of embryoid bodies produced by a transplantable teratoma of mice.
    Teresky AK; Marsden M; Kuff EL; Levine AJ
    J Cell Physiol; 1974 Oct; 84(2):319-32. PubMed ID: 4474183
    [No Abstract]   [Full Text] [Related]  

  • 62. [Vitelline morphogenesis in a teratocarcinoma of mice].
    Gaillard J
    C R Seances Acad Sci III; 1981 Nov; 293(12):671-4. PubMed ID: 6800587
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isolation of an aggregation inhibitory factor from non-adhesive mouse teratoma cells.
    Capelle CB; Meyer JT; Sorensen SE; Oppenheimer SB
    Exp Cell Res; 1981 Feb; 131(2):470-6. PubMed ID: 7202551
    [No Abstract]   [Full Text] [Related]  

  • 64. PCC4azal teratocarcinoma stem cell differentiation in culture. II. Morphological characterization.
    Lo CW; Gilula NB
    Dev Biol; 1980 Mar; 75(1):93-111. PubMed ID: 7371998
    [No Abstract]   [Full Text] [Related]  

  • 65. Pluripotent embryonic stem cell lines can be derived from tw5/tw5 blastocysts.
    Magnuson T; Epstein CJ; Silver LM; Martin GR
    Nature; 1982 Aug; 298(5876):750-3. PubMed ID: 7110310
    [No Abstract]   [Full Text] [Related]  

  • 66. [Letter: Experimental teratoma].
    Gaillard JA
    Nouv Presse Med; 1974 Jul; 3(27):1725. PubMed ID: 4858614
    [No Abstract]   [Full Text] [Related]  

  • 67. Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.
    Boon T; Kellermann O
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):272-5. PubMed ID: 264681
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neural differentiation in the OTT-6050 mouse teratoma: enzymatic and immunofluorescence characterization of a tumor fraction showing melanogenesis in neuroepithelial cells.
    Erdelyi E; VandenBerg SR; Raese J; Barchas JD; Rubinstein LJ; Herman MM
    Virchows Arch A Pathol Anat Histol; 1981; 393(1):27-37. PubMed ID: 6126948
    [No Abstract]   [Full Text] [Related]  

  • 69. Protein patterns of developmentally totipotent mouse teratocarcinoma cells and normal early embryo cells.
    Dewey MJ; Filler R; Mintz B
    Dev Biol; 1978 Jul; 65(1):171-82. PubMed ID: 567145
    [No Abstract]   [Full Text] [Related]  

  • 70. Heat shock gene expression is regulated during teratocarcinoma cell differentiation and early embryonic development.
    Wittig S; Hensse S; Keitel C; Elsner C; Wittig B
    Dev Biol; 1983 Apr; 96(2):507-14. PubMed ID: 6832481
    [No Abstract]   [Full Text] [Related]  

  • 71. Teratocarcinoma stem cells as a model for differentiation in the mouse embryo.
    Lehtonen E; Laasonen A; Tienari J
    Int J Dev Biol; 1989 Mar; 33(1):105-15. PubMed ID: 2485690
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Nucleolar organizer regions enumeration in testicular teratoma].
    Xu J; Li S; Yang D
    Zhonghua Wai Ke Za Zhi; 1997 Oct; 35(10):600-1. PubMed ID: 10678048
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Geminin Is Essential for Pluripotent Cell Viability During Teratoma Formation, but Not for Differentiated Cell Viability During Teratoma Expansion.
    Adler-Wailes DC; Kramer JA; DePamphilis ML
    Stem Cells Dev; 2017 Feb; 26(4):285-302. PubMed ID: 27821018
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neoplastic differentiation: characteristics of cell lines derived from a murine teratocarcinoma.
    Lehman JM; Speers WC; Swartzendruber DE; Pierce GB
    J Cell Physiol; 1974 Aug; 84(1):13-27. PubMed ID: 4858519
    [No Abstract]   [Full Text] [Related]  

  • 75. [Regulation of in vitro and in vivo differentiation of mouse embryonic stem cells, embryonic germ cells, and teratocarcinoma cells by TGFb family signaling factors].
    Gordeeva OF; Nikonova TM; Lifantseva NV
    Ontogenez; 2009; 40(6):403-18. PubMed ID: 20058783
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aggregation-deficient variants of the H6 teratocarcinoma cell line.
    Felix JS; Kartha S; Littlefield JW
    Prog Clin Biol Res; 1982; 97():173-92. PubMed ID: 7156167
    [No Abstract]   [Full Text] [Related]  

  • 77. Teratocarcinomas and other neoplasms as developmental defects in gene expression.
    Mintz B; Fleischman RA
    Adv Cancer Res; 1981; 34():211-78. PubMed ID: 7025592
    [No Abstract]   [Full Text] [Related]  

  • 78. [Mouse teratocarcinoma: isolation and characterization of two muscle cell lines (author's transl)].
    Boon T; Buckingham ME; Dexter DL; Jakob H; Jacob F
    Ann Microbiol (Paris); 1974; 125B(1):13-28. PubMed ID: 4468749
    [No Abstract]   [Full Text] [Related]  

  • 79. Teratomas obtained through extrauterine growth of seven-day mouse embryos.
    Damjanov I; Solter D; Belicza M; Skreb N
    J Natl Cancer Inst; 1971 Mar; 46(3):471-5 passim. PubMed ID: 5547311
    [No Abstract]   [Full Text] [Related]  

  • 80. Mouse teratocarcinoma cells.
    Jakob H; Nicolas JF
    Methods Enzymol; 1987; 151():66-81. PubMed ID: 3431455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.